2Fylstra DL.Tubal pregnancy:a review of current diagnosis and treatment[J].Obstet Gynecol Surv,1998,53(5):320-328.
3Tanaka T,Hayashi H,Kutsuzawa T,et al.Treatment of interstitial ectopic pregnancy with methotrexate:report of a successful case[J].Fertil Steril,1982,37(6):851-852.
4Barnhart K,Coutifaris C,Esposito M.The pharmacology of methotrexate[J].Expert Opinion on Pharmacotherapy,2001,2(3):409-417.
5Bayram M,Ozogul C,Dursun A,et al.Light and electron microscopy examination of the effects of methotrexate on the endosalpinx[J].Eur J Obstet Gynecol Reprod Biol,2005,120(1):96-103.
8Barnhart KT,Gosman G,Ashby R,et al.The medical management of ectopic pregnancy:a meta-analysis comparing "single dose" and "multidose" regimens[J].Obstet Gynecol,2003,101(4):778-784.
9Lipscomb GH,Givens VM,Meyer NL,et al.Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy[J].Am J Obstet Gynecol,2005,192(6):1844-1847.
10Nazac A,Gervase A,Bouyer J,et al.Predictor of success in methotrexate treatment of woman with unrupture tubal pregnancies[J].Ultra Obstet Gynecol,2003,21(2):181-185.
2Lin CY,Shih YT. Transabdominal ultrasound-guided intrageslationalsac single dose mtx injection in a tubal pregnancy [_ J ]. TaiwaneseJournal of Obstetrics and Gynecology,2010,49 (4) :536 -538.
3Poppe WA,Vandenbussche N. Postoperative day 3 serum humanchorionic gonadotropin decline as a predictor of persistent ectop-icpregnancy after linear salpingotomy [ J ]. Eur J Obstet Gynecol Re-prod Biol,2001,99(2) :249 -252.
